US-bound plane diverts to Canada after person from Ebola-hit region boards 'in error'

A plane from Paris to Detroit was forced to divert to Canada after a passenger from the Ebola-hit Democratic Republic of Congo boarded the plane "in error", officials have said.

US entry restrictions aimed at limiting the spread of the deadly virus meant the passenger should not have boarded the Air France plane, the US Customs and Border Protection (CBP) agency told the BBC.

Almost 140 people are believed to have died from Ebola in the outbreak in central Africa, with more than 600 suspected cases identified.

Officials did not specify if the passenger was showing symptoms of the virus or when the person was last in DR Congo.

Air France confirmed to US media that "at the request of US authorities, [the flight] was diverted to Montreal Airport after a Congolese passenger on board was denied entry into the United States".

The US border agency CBP said: "Air France boarded a passenger from the Democratic Republic of Congo in error on a flight to the United States."

The agency said it took "decisive action" to stop the flight landing at Detroit Metropolitan Wayne County Airport. It was diverted by about 500 miles (800km) to Montreal, Canada.

The US is restricting entry for people without US passports who were in DR Congo, South Sudan or Uganda in the last three weeks.

US passport holders and permanent residents who have been in those countries can only enter through Washington-Dulles International Airport in Virginia for enhanced screening.

The current Ebola outbreak has been declared a public health emergency of international concern by the World Health Organization.

The US Centers for Disease Control and Prevention said the risk to the US was relatively low, but it would introduce measures to prevent the disease from entering the country.

One American has tested positive - a doctor who was working with a medical missionary group in DR Congo. He is being treated in a special isolation ward at a hospital in Germany.

The Bundibugyo species of the virus does not yet have a vaccine, and it could take up to nine months before a vaccine against it is ready, the World Health Organization said on Wednesday.